SCHEMBL171527

SCHEMBL171527

C=C(C)c1ccccc1-c1ccc(C(F)(F)F)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 2/20 0.47
BACE1 P56817 1/20 0.47
GAA P10253 1/20 0.45
APOB P04114 3/20 0.44
MTTP P55157 3/20 0.44
KLRK1 P26718 4/20 0.43
MICA Q29983 4/20 0.43
RAET1L Q5VY80 3/20 0.43
TACR1 P25103 2/20 0.43
CYP2C8 P10632 1/20 0.42
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP1A2 P05177 1/20 0.41
POLB P06746 1/20 0.41
CYP2C19 P33261 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TRPV1 Q8NER1 1/20 0.40
MAOB P27338 1/20 0.40
CHUK O15111 1/20 0.39
TXNRD1 Q16881 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL171542 0.83 TRPV1 (0.54) KIF11BACE1GAAAPOBMTTP
SCHEMBL1588207 0.79 BCAT2 (0.52) BACE1GAAALDH1A1POLBHSD17B10
SCHEMBL29066698 0.78 SMN1; SMN2 (0.39) ALDH1A1MAOB
SCHEMBL10492731 0.78 KMT2A (0.40) GAAALDH1A1POLB
Xenalipin SCHEMBL29881739 0.77 CYP2C8 (0.58) KIF11BACE1GAAAPOBMTTP
Xenalipin SCHEMBL133087 0.77 CYP2C8 (0.58) KIF11BACE1GAAAPOBMTTP
SCHEMBL17840160 0.77 KIF11 (0.68) KIF11BACE1KDM4EALDH1A1CYP1A2
SCHEMBL2564888 0.76 BCAT2 (0.65) KIF11BACE1GAAKLRK1MICA
SCHEMBL8341064 0.76 KIF11 (0.47) KIF11BACE1GAAKLRK1MICA
SCHEMBL403609 0.76 GAA (0.51) KIF11BACE1GAAAPOBMTTP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1694644-B1 N-ARYL PIPERIDINE SUBSTITUTED BIPHENYLCARBOXAMIDES AS INHIBITORS OF APOLIPOPROTEIN B JANSSEN PHARMACEUTICA NV (BE) 2012-03-07 EP disclosed